About Apellis Pharma (APLS)
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more
- USD33.16
- USD34.27
- USD32.89
- USD73.80
- 20.80%
- 715M
- 3.73M
- 3.18M
- 4.1B
- 24.34
- -39.60%
Stock News
1 hour ago
Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.
MarketWatch
1 hour ago
BNP Paribas Signs €5.1 Billion Deal to Buy Axa’s Asset Manager
Yahoo
2 hours ago
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Yahoo
3 hours ago
Billionaire Paul Tudor Jones' Fund Just Sold Boeing and Bought This Popular Cryptocurrency Instead
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
